Financial Burden of Lymphedema Hospitalizations in the United States
Mya L Roberson, Paula D Strassle, Luther-King Okunade Fasehun, Daniel O Erim, E Gene Deune, Adeyemi A Ogunleye, Mya L Roberson, Paula D Strassle, Luther-King Okunade Fasehun, Daniel O Erim, E Gene Deune, Adeyemi A Ogunleye
Abstract
This cohort study uses data from the Healthcare Cost and Utilization Project Inpatient Sample to identify factors associated with high costs incurred during lymphedema-related hospitalizations in adults.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Figures
![Figure 1.. Association Between Factors and Extreme-Cost…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7893544/bin/jamaoncol-e207891-g001.jpg)
Extreme-cost hospitalizations were defined as those in the top 20th percentile (ie, ≥$10 893). Non-Hispanic (NH) other race/ethnicity included Asian or Pacific Islander, Native American, or other nonspecified race. Odds ratios were estimated using multivariable logistic regression and were adjusted for diagnosis site, age group, gender, race/ethnicity, insurance type, zip code income quartile, Charlson Comorbidity Index (CCI) score, hospital location and teaching status, hospital region, hospital size, and year of diagnosis.
![Figure 2.. Association Between Patient, Disease, Hospital…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7893544/bin/jamaoncol-e207891-g002.jpg)
Relative differences were estimated using multivariable generalized gamma regression and were adjusted for diagnosis site, age group, gender, race/ethnicity, insurance type, zip code income quartile, Charlson Comorbidity Index (CCI) score, hospital location and teaching status, hospital region, hospital size, and year of diagnosis. IQR indicates interquartile range.
Source: PubMed